,,ii #aaith ,,congress #ast ,session ,s4 #bgej ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,september #aj1 #bjbe ,mr4 ,cruz introduced the following bill2 which was read twice and referred to the ,committee on ,commerce1 ,science1 and ,transportation ,a ,,bill ,to require the ,director of the ,office of ,science and ,technology ,policy to establish a ,federal regulatory sandbox program for artificial intelligence1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,strengthening ,artificial intelligence ,normalization and ,diffusion ,by ,oversight and e,xperimentation ,act or the ,,sandbox ,act4 #b4 ,artificial ,intelligence ,regulatory ,sandbox ,program ,the ,national ,science and ,technology ,policy1 ,organization1 and ,priorities ,act of #aigf 7#db ,u4,s4,c4 #ffaa et seq47 is amended by adding at the end the following3 ,,vii ,artificial ,intelligence ,regulatory ,sandbox ,program #gja4 ,definitions ,in this title3 7#a7 ,agency ,the term agency has the meaning given the term in section #eea of title #e1 ,united ,states ,code4 7#b7 ,applicable agency ,the term applicable agency means an agency that has jurisdiction over the enforcement or implementation of a covered provision for which an applicant is seeking a waiver or modification under the ,program4 7#c7 ,artificial intelligence2 artificial intelligence system ,the terms artificial intelligence and artificial intelligence system have the meaning given the term artificial intelligence in section #ejjb of the ,national ,artificial ,intelligence ,initiative ,act of #bjbj 7#ae ,u4,s4,c4 #idja74 7#d7 ,artificial intelligence development method ,the term artificial intelligence development method means a business model or production method that1 in whole or in part1 uses one or more artificial intelligence systems4 7#e7 ,artificial intelligence product or service ,the term artificial intelligence product or service means a product or service that uses or contains1 in whole or in part1 one or more artificial intelligence systems4 7#f7 ,covered provision ,the term covered provision has the meaning given the term rule in section #hjd7c7 of title #e1 ,united ,states ,code1 including any associated guidance1 frequently asked questions publications1 bulletins1 or associated1 derivative material and any rule the adoption of which is expressly required by statute4 7#g7 ,director ,the term ,director means the ,director of the ,office of ,science and ,technology ,policy4 7#h7 ,health and safety risk ,the term health and safety risk means a risk that is likely to cause-- 7,a7 bodily harm to a human life 7including life before birth72 7,b7 loss of human life 7including life before birth72 or 7,c7 a substantial adverse effect on the health of a human 7including an unborn human74 7#i7 ,program ,the term ,program means the artificial intelligence regulatory sandbox program established pursuant to section #gjb7;a74 7#aj7 ,risk of economic damage ,the term risk of economic damage means likely to cause tangible1 physical harm to the property or assets of a consumer4 7#aa7 ,unfair or deceptive trade practice ,the term unfair or deceptive trade practice-- 7,a7 means an unfair or deceptive act or practice that is declared unlawful pursuant to section #e of the ,federal ,trade ,commission ,act 7#ae ,u4,s4,c4 #de72 or 7,b7 has the meaning given such term in-- 7i7 the ,policy ,statement of the ,federal ,trade ,commission on ,deception1 issued on ,october #ad1 #aihc2 or 7ii7 the ,policy ,statement of the ,federal ,trade ,commission on ,unfairness1 issued on ,december #ag1 #aihj4 #gjb4 ,establishment of ,artificial ,intelligence ,regulatory ,sandbox ,program 7a7 ,establishment 7#a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,director shall establish and operate1 in accordance with the requirements of this section1 an artificial intelligence regulatory sandbox program1 under which the ,director and persons may apply for a temporary waiver or modification of one or more covered provisions of an applicable agency in order to test1 experiment1 or temporarily provide to consumers artificial intelligence products or services or artificial intelligence development methods on a limited basis without being subject to the enforcement1 licensing1 or authorization requirements of such covered provisions4 7#b7 ,regulations ,in establishing the ,program under paragraph 7#a71 the ,director shall-- 7,a7 establish an application process for a temporary waiver or modification described in paragraph 7#a71 including the creation of a standardized form for applicants to provide the information required under subsection 7c72 7,b7 establish a process by which the ,director may submit an application for a temporary waiver or modification described in paragraph 7#a7 in accordance with subsection 7c77#c72 and 7,c7 establish a process for review of applications submitted pursuant to a process established under subparagraph 7,a7 or 7,b7 in accordance with the requirements of this section for assessing whether an application submitted for the ,program presents a health and safety risk1 a risk of economic damage1 or a risk of unfair or deceptive trade practices1 which shall be-- 7i7 published in the ,federal ,register and made publicly available with a detailed list of the criteria used to make such assessments2 and 7ii7 subject to public comment before final publication in the ,federal ,register4 7b7 ,purpose ,the purpose of the ,program is to incentivize-- 7#a7 the development of current or new artificial intelligence products and services and artificial intelligence development methods2 7#b7 the expansion of economic opportunities from artificial intelligence development2 7#c7 the creation of jobs from artificial intelligence development2 and 7#d7 the creation of opportunities for artificial intelligence innovation in the ,united ,states4 7c7 ,application process for waivers and modifications 7#a7 ,in general ,to apply for a waiver or modification under the ,program1 an applicant shall1 pursuant to the process established under subsection 7a77#b77;,a71 submit to the ,director an application therefor that includes-- 7,a7 confirmation that the applicant-- 7i7 is subject to the jurisdiction of the ,federal ,government2 and 7ii7 has established1 or plans to establish not later than #ahj days after the date on which the applicant enters into a written agreement under subsection 7e71 a business that is incorporated or has a principal place of business in the ,united ,states from which the artificial intelligence products or services or artificial intelligence development methods are deployed2 7,b7 relevant contact information1 including the legal name1 address1 telephone number1 email address1 and website of the applicant2 7,c7 a description of any criminal conviction of the applicant or any senior management personnel or director of the business of the applicant2 and 7,d7 a description of any artificial intelligence product or service or artificial intelligence development method to be tested1 experimented1 or deployed for which the applicant is requesting a waiver or modification1 and for each such artificial intelligence product or service or artificial intelligence development method-- 7i7 identification of each covered provision that the applicant seeks to have waived or modified during participation in the ,program and the reasons why the waiver or modification is needed2 7ii7 a description of the manner by which the product or service or development method would-- 7,i7 benefit consumers2 7,,ii7 enhance the operational efficiency of the business of the applicant2 7,,iii7 expand economic opportunities2 7,,iv7 create jobs2 or 7,v7 further the innovation or development of artificial intelligence2 7iii7 an explanation of how potential benefits of the product or service or development method outweigh the risks1 taking into account any mitigation measures1 which shall include-- 7,i7 a description of the reasonably foreseeable risks associated with waiving or modifying each covered provision identified under clause 7i7 during participation in the ,program1 including any-- 7aa7 health and safety risk2 7bb7 risk of economic damage2 and 7cc7 risk of unfair or deceptive trade practices2 7,,ii7 the manner in which the applicant intends to reasonably mitigate any risk identified pursuant to subclause 7,i72 7iv7 the requested time periods for which the waiver or modification of each covered provision identified under clause 7i7 would apply2 7v7 confirmation that the applicant understands that the applicant will be subject to and must comply with all statutes and regulations after the conclusion of testing1 experimenting1 or deploying such product or service or development method under the ,program2 and 7vi7 a list of each agency that may have jurisdiction1 in whole or in part1 over the product or service or development method to be tested1 experimented1 or deployed by the applicant4 7#b7 ,assistance ,the ,director may1 upon request1 consult with an applicant and provide assistance completing an application described in paragraph 7#a71 including by-- 7,a7 identifying-- 7i7 the likely covered provisions that could be relevant and eligible for a waiver or modification under the ,program2 and 7ii7 the agencies with authority over the covered provisions identified under clause 7i72 and 7,b7 providing anonymized information on other relevant applications or aggregate applicant trends4 7#c7 ,director-submitted application ,the ,director may submit an application to waive or modify any covered provision under the ,program1 if in the opinion of the ,director the waiver or modification proposed in the application will advance the development1 deployment1 or use of artificial intelligence in the ,united ,states4 7d7 ,agency review 7#a7 ,transmission ,not later than #ad days after the date on which the ,director receives a completed application under paragraph 7#a7 of subsection 7c7 or submits a completed application under paragraph 7#c7 of that subsection1 the ,director shall submit a copy of the application to the head of each applicable agency4 7#b7 ,review ,the head of an applicable agency shall review an application received under paragraph 7#a7 with respect to the covered provision or provisions under the jurisdiction of the agency and solicit input1 and demonstrate due consideration of such input1 from the private sector and technical experts with relevance to the ,program1 on-- 7,a7 whether the plan of the applicant with respect to testing1 experimenting1 or deploying an artificial intelligence product or service or an artificial intelligence development method would-- 7i7 benefit consumers2 7ii7 enhance the operational efficiency of the business of the applicant2 7iii7 expand economic opportunities2 7iv7 create jobs2 or 7v7 further the innovation or development of artificial intelligence2 and 7,b7 whether the potential benefits of the plan outweigh any-- 7i7 health and safety risk2 7ii7 risk of economic damage2 and 7iii7 risk of unfair or deceptive trade practices4 7#c7 ,method ,the head of an applicable agency may conduct its review of applications received under paragraph 7#b7 by establishing advisory boards or working groups to review and provide input on the applications4 7#d7 ,agency decision 7,a7 ,in general ,subject to subparagraph 7,b71 the head of an applicable agency who receives a copy of an application under paragraph 7#a7 shall1 taking into consideration the recommendations of the advisory board of the applicable agency1 make the agency decision to grant or deny the application with respect to the covered provision or provisions requested to be waived or modified that are under the jurisdiction of the agency4 7,b7 ,in part approval ,if more than one applicable agency receives a copy of an application under paragraph 7#a7-- 7i7 the head of each applicable agency1 with input from the advisory board of the applicable agency1 shall grant or deny the waiver or modification of each covered provision over which the applicable agency has jurisdiction2 and 7ii7 7,i7 if each applicable agency that receives an application under paragraph 7#a7 grants the request for a waiver or modification1 the ,director shall grant the entire application2 or 7,,ii7 if an applicable agency denies part of an application and another applicable agency grants part of the application1 the ,director shall approve the application in part and specify in the decision which covered provisions are waived or modified4 7#e7 ,record of agency decision 7,a7 ,in general ,not later than #ij days after receiving a copy of an application under paragraph 7#a71 the head of an applicable agency shall approve or deny the application and submit to the ,director a record of the agency decision4 7,b7 ,elements ,the record of the agency decision required by subparagraph 7,a7 to be submitted by the head of an applicable agency shall include-- 7i7 a description of each covered provision over which the applicable agency has jurisdiction for enforcement or implementation that the applicant is seeking to have waived or modified and a list of the reasonably foreseeable risks1 if any1 that could result from the requested waiver or modification1 including any-- 7,i7 health and safety risk2 7,,ii7 risk of economic damage2 and 7,,iii7 risk of unfair or deceptive trade practices2 7ii7 if the application is approved1 a description1 if applicable1 of-- 7,i7 the manner by which the applicant will mitigate the risks identified in clause 7i72 and 7,,ii7 the manner by which consumers will be protected during the term for which the waiver or modification remains in effect2 7iii7 if the head of the applicable agency denies the waiver or modification-- 7,i7 a description of the reasons for the denial1 including-- 7aa7 an explanation of the manner by which a waiver or modification could cause any of the risks described in clause 7i72 and 7bb7 the likelihood of such reasonably foreseeable risks occurring2 and 7,,ii7 the reasons why the application cannot be approved in part or reformed to mitigate the risks described under subclause 7,i77aa7 and any information the head of the applicable agency relied on to support these reasons2 and 7iv7 if the head of the applicable agency would deny the waiver or modification unless the risks described in clause 7i7 are mitigated1 a recommendation of the means by which the applicant can mitigate such risks4 7,c7 ,no record submitted ,if the head of the applicable agency does not submit a record of the agency decision by the deadline required by subparagraph 7,a71 the ,director shall presume that the head of the applicable agency does not object to the granting of the waiver or modification requested by the applicant and may proceed with the application4 7,d7 ,extension ,the head of the applicable agency may request one #cj-;day extension of the deadline required by subparagraph 7,a7 for submission of the record of the agency decision4 7,e7 ,expedited review ,if the head of the applicable agency provides a recommendation described in subparagraph 7,b77iv71 the ,director shall provide the applicant #fj days to make necessary changes to the application1 and the applicant may resubmit the application to the head of the applicable agency for expedited review of not more than #fj days from the date of resubmission of the completed application4 7e7 ,written agreement 7#a7 ,in general ,if the head of an agency1 or the ,director upon an appeal under subsection 7g71 grants the entire application or part of the application under subsection 7d77#d71 any waiver or modification requested shall not be effective until the applicant enters into a written agreement with the ,director and the head of the agency that describes-- 7,a7 each covered provision that is waived or modified under the ,program2 and 7,b7 the terms the applicant shall abide by to mitigate any risk described in the record of the agency decision pursuant to subsection 7d77#e77;,b77i74 7#b7 ,requirement ,each written agreement entered into under paragraph 7#a7 shall include a requirement that the applicant notify the ,director and the head of any relevant applicable agency of any incident that results in harm to the health and safety of a consumer1 economic damage1 or an unfair or deceptive trade practice under the ,program not later than #gb hours after the incident occurs4 7#c7 ,timeline ,the ,director shall provide to the applicant a copy of the written agreement described in paragraph 7#a7 not later than #de days after the date on which the application is granted1 in part or in whole1 under subsection 7d77#d74 7f7 ,publication of ,director-,submitted applications and utilization by applicants 7#a7 ,in general ,if the head of an agency1 or the ,director upon an appeal under subsection 7g71 grants a ,director-submitted application1 in whole or part1 under subsection 7d77#d71 the ,director shall publish in the ,federal ,register notice of any waiver or modification granted and any information required to be submitted to the ,director for an applicant to utilize such waiver or modification under paragraph 7#b74 7#b7 ,authority ,in the case described in paragraph 7#a71 any person may submit an application to utilize such waiver or modification1 pursuant to fulfilling the requirements of subsection 7e7 and any requirement developed by the ,director under paragraph 7#c74 7#c7 ,process for utilization ,the ,director may develop a standardized process for the submission and consideration of an application to utilize a waiver or modification of a covered provision granted under paragraph 7#a74 7g7 ,appeals 7#a7 ,in general ,if the head of an applicable agency denies an application under subsection 7d77#d71 the applicant may submit to the ,director an appeal for reconsideration1 or in the case of a ,director-submitted application shall prepare a statement1 which shall-- 7,a7 address the comments in the record of the agency decision submitted under subsection 7d77#e7 that resulted in denial of the application2 and 7,b7 include the manner by which the applicant plans to mitigate the risks identified in the record of the agency decision4 7#b7 ,response ,not later than #fj days after receiving an appeal under paragraph 7#a71 the ,director shall-- 7,a7 determine whether the appeal sufficiently addresses the concerns raised in the record of the agency decision submitted under subsection 7d77#e72 and 7,b7 7i7 if the ,director determines that the appeal sufficiently addresses the concerns1 file a record of the agency decision and provide a statement detailing how the concerns have been mitigated and approve the application2 or 7ii7 if the ,director determines that the appeal does not sufficiently address the concerns1 file a record of the agency decision and provide a statement detailing how the concerns have not been mitigated and deny the application4 7h7 ,judicial review ,for purposes of review under section #gjd of title #e1 ,united ,states ,code1 the following shall be considered a final agency action3 7#a7 ,a record of the agency decision submitted under subsection 7d77#e74 7#b7 ,the granting of a request to renew a waiver or modification under subsection 7i77#c77;,c74 7#c7 ,the failure of the ,director to provide a written agreement subject to the terms of subsection 7e74 7#d7 ,the revocation of a waiver or modifications under subsection 7j74 7i7 ,period of waiver or modification 7#a7 ,initial period ,except as provided in this subsection1 a waiver or modification granted under the ,program shall be for a term of #b years4 7#b7 ,notification before ending offering ,if a person decides to end deployment of its artificial intelligence product1 service1 or method before the end of the initial period described in paragraph 7#a71 the person shall1 not later than #cj days before the date on which the person ends deployment of the product1 service1 or method1 submit to the ,director a report on actions taken by the person to ensure consumers have not been harmed as a result of the termination of the product1 service1 or method4 7#c7 ,renewal 7,a7 ,in general ,the person granted a waiver or modification under the ,program may request for renewal of the waiver or modification for a maximum of #d additional #b-year periods4 7,b7 ,notification ,not later than #cj days before the end of an initial period under paragraph 7#a71 a person that is granted a waiver or modification under the ,program shall notify the ,director if the person intends to seek renewal under subparagraph 7,a74 7,c7 ,decision ,the ,director shall grant a request made pursuant to subparagraph 7,a71 unless the ,director determines that-- 7i7 relevant information or circumstances have materially changed since the waiver or modification was granted and the person must submit a new or amended application2 or 7ii7 the person granted the waiver or modification is not in compliance with the terms of the written agreement entered into pursuant to subsection 7e7 and the person is unable to correct the action under subsection 7j77#b74 7j7 ,revocation ,if the ,director determines that a person that was granted a waiver or modification under the ,program is not in compliance with the terms of the written agreement entered into pursuant to subsection 7e71 the ,director-- 7#a7 shall give the person #cj days to correct the action1 or additional #cj-;day periods if the ,director considers it appropriate2 7#b7 if the person does not correct the action by the end of the #cj-;day period1 the ,director may end the participation of the person in the ,program by revoking the waiver or modification4 7k7 ,terms ,a person for which a waiver or modification is granted under the ,program shall be subject to the following terms3 7#a7 ,no existing right of action of a consumer to seek actual damages or an equitable remedy may be waived or modified under the ,program4 7#b7 ,while a waiver or modification is in effect1 and the person is in compliance with the written agreement entered into pursuant to subsection 7e71 the person shall not be subject to the criminal or civil enforcement of a covered provision specifically identified in the waiver or modification4 7#c7 ,an agency may not file or pursue any punitive action against the person during the period for which the waiver or modification is in effect1 including a civil penalty1 fine1 or license suspension or revocation for a violation of a covered provision identified in the waiver or modification1 unless the person is not in compliance with the written agreement entered into pursuant to subsection 7e74 7#d7 ,the person shall not have immunity related to any criminal offense that is not expressly identified in the waiver or modification4 7#e7 ,the ,federal ,government shall not be responsible for any business losses if the waiver or modification is revoked at any time1 including any action brought under section #acdf7;b7 or #adia of title #bh1 ,united ,states ,code4 7#f7 ,the person shall notify the ,director and the head of any applicable agency of any incident that results in harm to the health and safety of a consumer1 economic damage1 or an unfair or deceptive trade practice under the ,program not later than #gb hours after the incident occurs4 7#g7 ,the person shall abide by all terms of the written agreement entered into pursuant to subsection 7e74 7l7 ,consumer protection ,before deploying an artificial intelligence product or service to consumers under a waiver or modification granted under the ,program1 and throughout the period the waiver or modification remains in effect1 a person shall disclose1 through a publicly accessible website or similar public means1 the following to consumers3 7#a7 ,the name and contact information of the person4 7#b7 ,a description of the participation of the person in the ,program1 and if applicable1 disclosure that the person does not have a license or other authorization to provide artificial intelligence products or services under provisions not waived or modified under the ,program4 7#c7 ,if applicable1 that the artificial intelligence product or service is undergoing testing and may not function as intended and may expose the consumer to certain risks as identified in the record of the agency decision of the applicable agency submitted under subsection 7d77#e74 7#d7 ,that the person is not immune from existing civil liability for any loss or damage caused by the artificial intelligence product or service4 7#e7 ,that the person is not immune from criminal prosecution for violations of covered provisions that are not waived or modified under the ,program4 7#f7 ,that the artificial intelligence product or service is a temporary demonstration and may be discontinued at the end of the initial period under paragraph 7#a7 of subsection 7i7 or before the end of the initial period under paragraph 7#b7 of that subsection4 7#g7 ,the expected commencement date of the initial period under subsection 7i77#a74 7#h7 ,the contact information of the ,national ,artificial ,intelligence ,initiative ,office and that the consumer may contact the ,initiative ,office to file a complaint4 7m7 ,record keeping 7#a7 ,in general ,a person who is granted a waiver or modification under the ,program shall retain all records1 documents1 and data directly related to the participation of the person in the ,program4 7#b7 ,request for documents ,upon request by the ,director1 a person granted a waiver or modification under the ,program shall make available for inspection any record1 document1 or data retained under paragraph 7#a74 7n7 ,reports 7#a7 ,persons granted a waiver or modification 7,a7 ,in general ,each person who is granted a waiver or modification under the ,program shall submit to the ,director a report that includes-- 7i7 if applicable1 the number of consumers participating in or receiving the artificial intelligence product or service or the artificial intelligence development method offered by the person under the ,program2 7ii7 an assessment of the likely risks and the manner by which the person is mitigating those risks1 consistent with the terms of the written agreement entered into under subsection 7e72 7iii7 an identification of any previously unanticipated risks that have manifested during the deployment of the artificial intelligence product or service or the artificial intelligence development method2 7iv7 a description of any adverse incident and any action taken by the person to repair the harm to consumers2 and 7v7 a description of the benefits of the waiver or modification1 including1 if applicable1 studies1 surveys1 financial benefits1 or additional quantitative measures demonstrating such benefits4 7,b7 ,timing ,each person shall submit a report required under subparagraph 7,a7-- 7i7 #dj days after the commencement of the period for which a waiver or modification is granted under the ,program2 7ii7 #cj days after the halfway mark of the period for which a waiver or modification is granted under the ,program2 and 7iii7 #cj days before the expiration of-- 7,i7 the period for which a waiver or modification is initially granted under the ,program2 and 7,,ii7 each #b-year period for which the waiver or modification is renewed under subsection 7i77#c74 7#b7 ,annual report to ,congress ,not later than #a year after the date of the enactment of the ,strengthening ,artificial intelligence ,normalization and ,diffusion ,by ,oversight and e,xperimentation ,act1 and annually thereafter1 the ,director shall submit to ,congress a report on the ,program1 which shall include1 for the #a-year period preceding the submission of the report-- 7,a7 the number of applications approved received and the number of applications approved2 7,b7 the name and a description of each applicant that was granted a waiver or modification under the ,program2 7,c7 a description of the benefits to the public from the ,program2 7,d7 a description of any harm to the public from the ,program2 7,e7 the covered provisions that have been waived or modified and the number of times such provisions have been waived or modified2 7,f7 the total number of consumers affected by such waivers or modifications described in subsection 7,e72 and 7,g7 all applicant1 ,director1 and agency materials related to the ,program4 7o7 ,coordination ,with ,state artificial intelligence programs ,the ,director shall-- 7#a7 establish mechanisms for sharing information with ,state programs that are similar or comparable to the ,program2 7#b7 coordinate application review processes where jurisdictions overlap2 7#c7 accept joint applications for projects benefitting from both ,federal and ,state regulatory relief2 and 7#d7 work to harmonize testing approaches whenever feasible4 7p7 ,rule of construction ,nothing in this section shall be construed-- 7#a7 to require a person that is granted a waiver or modification under the ,program to publicly disclose proprietary information1 including trade secrets or commercial or financial information that is privileged or confidential2 or 7#b7 to affect any other provision of law that is not included in a waiver or modification provided under the ,program4 7q7 ,sunset ,the ,program shall terminate on the date that is #ab years after the date on which the ,director establishes the ,program under subsection 7a74 #gjc4 ,congressional review of covered provisions 7a7 ,joint resolution of approval defined ,in this section1 the term joint resolution of approval means only a joint resolution of either ,house of ,congress-- 7#a7 the matter after the resolving clause of which contains only-- 7,a7 a list of some or all of the covered provisions that were identified under subsection 7b77#a7 in a special message submitted to ,congress under that subsection2 and 7,b7 a provision that immediately repeals or adopts amendments to the covered provisions listed under subparagraph 7,a7 upon enactment of the joint resolution of approval2 and 7#b7 upon which ,congress completes action before the end of the first period of #fj legislative days after the date on which the special message is received by ,congress4 7b7 ,submission 7#a7 ,in general ,not later than the first day on which both ,houses of ,congress are in session after ,may #a of each year1 the ,director of the ,office of ,science and ,technology ,policy 7in this section referred to as the ,director7 shall submit to ,congress a special message that details each covered provision that the ,director recommends should be amended or repealed as a result of persons being able to operate safely without those covered provisions under the artificial intelligence regulatory sandbox program established under section #eajg7;b74 7#b7 ,elements ,the special message submitted under paragraph 7#a7 shall include-- 7,a7 a list of each covered provision waived or modified and how many times that provision has been waived or modified2 7,b7 a list of each covered provision that is the subject of an application for waiver or modification that has been denied1 how many times applications have been denied1 and a summary of the reasons behind such denial2 7,c7 a list of any covered provision that the ,director determines should be repealed1 for any reason1 including a brief rationale for the ,director's determination2 7,d7 a list of any covered provision that the ,director determines should be amended1 including the recommended textual changes to the covered provision1 including a brief rationale for the ,director's determination2 and 7,e7 an explanation of why each covered provision described in subparagraphs 7,a7 and 7,b7 should be amended or repealed4 7#c7 ,delivery to ,house and ,senate2 printing ,each special message submitted under paragraph 7#a7 shall be-- 7,a7 delivered to the ,clerk of the ,house of ,representatives and the ,secretary of the ,senate2 and 7,b7 printed in the ,congressional ,record4 7c7 ,approval by ,congress 7#a7 ,introduction ,beginning on the date on which the ,director submits a special message to ,congress under subsection 7b77#a71 any member of the ,senate or ,house of ,representative may introduce a joint resolution of approval relating to the special message4 7#b7 ,consideration in house of representatives 7,a7 ,committee referral ,a joint resolution of approval introduced in the ,house of ,representatives shall be referred to the appropriate committee of the ,house of ,representatives4 7,b7 ,reporting and discharge ,if the committee to which a joint resolution of approval has been referred to has not reported the joint resolution of approval within #aj legislative days after the date of referral1 the committee shall be discharged from further consideration of the joint resolution4 7,c7 ,proceeding to consideration ,beginning on the third legislative day after the committee to which a joint resolution of approval has been referred reports the joint resolution of approval to the ,house or has been discharged from further consideration thereof1 it shall be in order to move to proceed to consider the joint resolution of approval in the ,house4 ,all points of order against the motion are waived4 ,such a motion shall not be in order after the ,house has disposed of a motion to proceed on the joint resolution of approval4 ,the previous question shall be considered as ordered on the motion to its adoption without intervening motion4 ,the motion shall not be debatable4 ,a motion to reconsider the vote by which the motion is disposed of shall not be in order4 7,d7 ,floor consideration ,the joint resolution of approval shall be considered as read4 ,all points of order against the joint resolution of approval and against its consideration are waived4 ,the previous question shall be considered as ordered on the joint resolution of approval to final passage without intervening motion except #b hours of debate equally divided and controlled by the sponsor of the joint resolution of approval 7or a designee7 and an opponent4 ,a motion to reconsider the vote on passage of the joint resolution of approval shall not be in order4 7#c7 ,consideration in the senate 7,a7 ,committee referral ,a joint resolution of approval introduced in the ,senate shall be referred to the appropriate committee of the ,senate4 7,b7 ,reporting and discharge ,if the committee to which a joint resolution has been referred has not reported the joint resolution of approval within #aj legislative days after the date of referral of the joint resolution1 the committee shall be discharged from further consideration of the joint resolution and the joint resolution shall be placed on the appropriate calendar4 7,c7 ,proceeding to consideration ,notwithstanding ,rule ,,xxii of the ,standing ,rules of the ,senate1 it is in order at any time after the committee to which a joint resolution has been referred reports a joint resolution of approval or has been discharged from consideration of such a joint resolution to move to proceed to the consideration of the joint resolution of approval4 ,the motion to proceed is not debatable4 ,the motion is not subject to a motion to postpone4 ,a motion to reconsider the vote by which the motion is agreed to or disagreed to shall not be in order4 7,d7 ,rulings of the chair on procedure ,appeals from the decisions of the ,chair relating to the application of the rules of the ,senate to the procedure relating to a joint resolution of approval shall be decided by the ,senate without debate4 7#d7 ,rules relating to senate and house of representatives 7,a7 ,treatment of senate joint resolution of approval in house ,in the ,house of ,representatives1 the following procedures shall apply to a joint resolution of approval received from the ,senate 7unless the ,house has already passed a joint resolution relating to the same proposed action73 7i7 ,the joint resolution of approval shall be referred to the appropriate committee of the ,house of ,representatives4 7ii7 ,if the committee to which a joint resolution of approval has been referred has not reported the joint resolution of approval within #b legislative days after the date of referral1 the committee shall be discharged from further consideration of the joint resolution4 7iii7 ,beginning on the third legislative day after the committee to which a joint resolution has been referred reports the joint resolution of approval to the ,house or has been discharged from further consideration thereof1 it shall be in order to move to proceed to consider the joint resolution of approval in the ,house4 ,all points of order against the motion are waived4 ,such a motion shall not be in order after the ,house has disposed of a motion to proceed on the joint resolution of approval4 ,the previous question shall be considered as ordered on the motion to its adoption without intervening motion4 ,the motion shall not be debatable4 ,a motion to reconsider the vote by which the motion is disposed of shall not be in order4 7iv7 ,the joint resolution of approval shall be considered as read4 ,all points of order against the joint resolution and against its consideration are waived4 ,the previous question shall be considered as ordered on the joint resolution to final passage without intervening motion except #b hours of debate equally divided and controlled by the sponsor of the joint resolution of approval 7or a designee7 and an opponent4 ,a motion to reconsider the vote on passage of the joint resolution of approval shall not be in order4 7,b7 ,treatment of house joint resolution of approval in senate 7i7 ,receipt before passage ,if1 before the passage by the ,senate of a joint resolution of approval1 the ,senate receives an identical joint resolution of approval from the ,house of ,representatives1 the following procedures shall apply3 7,i7 ,that joint resolution of approval shall not be referred to a committee4 7,,ii7 ,with respect to that joint resolution of approval-- 7aa7 the procedure in the ,senate shall be the same as if no joint resolution had been received from the ,house of ,representatives2 but 7bb7 the vote on passage shall be on the joint resolution from the ,house of ,representatives4 7ii7 ,receipt after passage ,if1 following passage of a joint resolution of approval in the ,senate1 the ,senate receives an identical joint resolution of approval from the ,house of ,representatives1 that joint resolution shall be placed on the appropriate ,senate calendar4 7iii7 ,no companion measure ,if a joint resolution of approval is received from the ,house1 and no companion joint resolution of approval has been introduced in the ,senate1 the ,senate procedures under this subsection shall apply to the ,house joint resolution of approval4 7,c7 ,application to revenue measures ,the provisions of this paragraph shall not apply in the ,house of ,representatives to a joint resolution that is a revenue measure4 7#e7 ,rules of house of representatives and senate ,this subsection is enacted by ,congress-- 7,a7 as an exercise of the rulemaking power of the ,senate and the ,house of ,representatives1 respectively1 and as such is deemed a part of the rules of each ,house1 respectively1 and supersedes other rules only to the extent that it is inconsistent with such rules2 and 7,b7 with full recognition of the constitutional right of either ,house to change the rules 7so far as relating to the procedure of that ,house7 at any time1 in the same manner1 and to the same extent as in the case of any other rule of that ,house4 4